News

liver cancer
Transarterial radioembolization (TARE) is safe and can be an effective method of treatment for patients with intermediate or advanced-stage HCC that does not respond to transarterial chemoembolization (TACE), according to a study published in Cardiovascular and Interventional Radiology. Such… Read More
liver drawn
A swivel arm can facilitate easier repositioning of the access arm during and after cone-beam computed tomography (CBCT) acquisition. Researchers reported their findings in the British Journal of Radiology. The study’s authors pursued this investigation to determine whether a swivel arm board is a… Read More
liver red and blue
Patients treated with percutaneous radiofrequency ablation (RFA) combined with transarterial chemoembolization (RFA/TACE) had better outcomes for single hypervascular hepatocellular carcinoma (HCC) than those treated only with RFA. Researchers reported their findings in Oncology Letters. The… Read More
renal cell carcinoma
Researchers compared two methods of treating renal cell carcinoma (RCC) and found that transarterial chemoembolization using drug-eluting embolic agent (DEE) saturated with doxorubicin appears safe and effective, compared with treatment with transarterial embolization (TAE). RCC is often treated… Read More
kidneys
Over the long term, patients who received percutaneous renal cryoablation had low recurrence rates with preserved renal function, according to a study published in the Journal of Vascular and Interventional Radiology. The low recurrence rates and preserved renal function were seen even in patients… Read More
wrist and glove
The transradial approach appears to allow safe access and is feasible in patients undergoing hepatic chemoembolization, researchers reported in the Journal of Vascular and Interventional Radiology. Although the transradial approach is often used in coronary angioplasty and stent placement, it is… Read More
digestive system
Prophylactic temporary occlusion of the cystic artery with a detachable coil during yttrium-90 (Y90) radioembolization seems to be a feasible, effective way to limit the uptake of Y90 in the gallbladder. Researchers reported their findings in CardioVascular and Interventional Radiology. Radiation… Read More
risk assessment
Albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) grades can accurately predict survival in high-risk patients undergoing conventional transarterial chemoembolization for hepatocellular carcinoma (HCC), according to a study published in the Journal of Vascular and Interventional… Read More
guideline
The Society of Interventional Radiology (SIR) has published a quality improvement guideline for transarterial chemoembolization and embolization of hepatic malignancy. The guideline was developed via a literature search, followed by critical review of peer-reviewed studies and level of evidence.… Read More
liver
Transarterial radioembolization with yttrium-90 (Y90) microspheres shows promise as a safe, effective treatment for patients with unresectable combined hepatocellular-cholangiocarcinoma (cHCC-CC), a rare and aggressive form of primary liver cancer.  Researchers chose to investigate transarterial… Read More